Islet cell transplant plus surgery for high fistula risk
Part of Cancer clinical trials.
This Phase 1/2 study tests whether adding an islet (insulin-producing cell) transplant at the time of pancreatic-region surgery is safe and helps prevent a serious surgical complication called a postoperative fistula. It is for people whose surgery is considered high risk for developing that complication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- Your tumor is in the pancreas head/nearby area (duodenum or ampulla) and may include certain pancreatic cysts with cancer
- Your cancer team plans surgery with the goal of fully removing the tumor, and they agree this fits the study
- You are considered high risk for a postoperative pancreatic fistula based on tests before surgery and a risk score checked during surgery
- You can have major abdominal surgery and do not have conditions that would make it unsafe (including certain diabetes or major health limitations)
- You can follow study procedures, provide written consent, and (if applicable) use reliable contraception and do required pregnancy testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a short course of radiation before surgery can lower the risk of a pancreatic leak (a common complication). It is for people who are overweight, older than 45, and have a small pancreatic duct.
This trial tests two different surgical techniques for removing pancreatic cancer tumors that can be surgically removed. Researchers want to see if operating on the main artery first leads to better outcomes than the standard approach.
This study looks at outcomes after a procedure called TPIAT (total pancreatectomy with islet auto-transplantation), which aims to improve insulin function and blood-sugar control. It may help doctors better understand how people do over time after the procedure.
This Phase 3 trial studies a pancreatic surgery approach (pylorus-preserving Whipple or similar) and, in some cases, moving your insulin-making cells into your body to help prevent a dangerous post-surgery leak from the pancreas. It may help people who are considered high risk for this complication based on pancreas texture and duct size.
This trial tests a surgery that removes the whole pancreas and then puts your own insulin-making cells back into your liver. It is for people with certain types of pancreatic or nearby tumors who also have a soft pancreas and a very narrow main duct, and who still make some insulin.
This study tests if octreotide microspheres (a slow-release drug) can prevent pancreatic fistula—a common complication after surgery to remove the tail of the pancreas. The goal is to help patients heal with fewer complications.
Hear when a new Adenocarcinoma of the Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.